Technology
Health
Biotechnology

Erytech Pharma

$6.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.90 (-12.95%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell Erytech Pharma and other stocks, options, ETFs, and crypto commission-free!

About ERYP

Erytech Pharma S.A. American Depositary Shares, also called Erytech Pharma, is a biopharmaceutical company, which develops medical products. Read More It engages in developing and producing therapeutic products for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

Employees
172
Headquarters
Lyon, Rhone-Alpes
Founded
2004
Market Cap
122.38M
Price-Earnings Ratio
Dividend Yield
Average Volume
603.60
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$11.89
52 Week Low
$5.45

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Medical
Cancer Prevention
Pharmaceutical
2016 IPO

ERYP News

ReutersJun 25

BRIEF-Erytech Announces Immune Modulation Strategic Collaboration With SQZ Biotechnologies

11

ERYP Earnings

-$0.73
-$0.63
-$0.53
-$0.43
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 12, Pre-Market

More ERYP News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.